株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ビリルビン血液検査の世界市場:2020年~2024年

Global Bilirubin Blood Test Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 823151
出版日 ページ情報 英文 100 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.11円で換算しております。
Back to Top
ビリルビン血液検査の世界市場:2020年~2024年 Global Bilirubin Blood Test Market 2020-2024
出版日: 2020年01月14日 ページ情報: 英文 100 Pages
概要

世界のビリルビン血液検査市場は、2020年から2024年の予測期間中に8%のCAGRで成長し、5億6,250万米ドルの規模に達する見込みです。市場は、黄疸および肝疾患の有病率の増加に牽引されています。さらに、非侵襲的な治療手段に対する需要の増加が、市場成長を後押しすると予想されています。

当レポートでは、世界のビリルビン血液検査市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • バリューチェーン分析
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 2019年の市場規模
  • 市場規模と予測2019-2024
  • 市場の見通し

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第6章 市場セグメンテーション:タイプ別

  • 市場セグメンテーション:タイプ別
  • 比較:タイプ別
  • 幼児-市場規模と予測2019-2024
  • 成人-市場規模と予測2019-2024
  • 市場機会:タイプ別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米-市場規模と予測2019-2024
  • 欧州-市場規模と予測2019-2024
  • アジア-市場規模と予測2019-2024
  • その他の地域-市場規模と予測2019-2024
  • 主要国
  • 市場機会

第9章 成長要因と課題

  • 市場成長要因
  • 市場課題

第10章 市場動向

  • 戦略的提携の増加
  • 非侵襲的な治療手段に対する需要の増加
  • ビリルビン検査に対する政府の取り組みと資金

第11章 ベンダー情勢

  • 概要
  • 創造的破壊の状況
  • 競争シナリオ

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Danaher Corp.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke Philips NV
  • Merck KGaA
  • Randox Laboratories Ltd.
  • Reichert Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

第13章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第14章 TECHNAVIOについて

目次
Product Code: IRTNTR40873

Technavio has been monitoring the global bilirubin blood test market and it is poised to grow by USD 562.5 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our reports on bilirubin blood test market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of jaundice and liver diseases. In addition, increasing demand for non-invasive procedures is anticipated to boost the growth of the bilirubin blood test market as well.

Market Segmentation

Technavio's global bilirubin blood test market is segmented as below:

Type

  • Infants
  • Adults

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for bilirubin blood test market growth

This study identifies increasing demand for non-invasive procedures as the prime reasons driving the bilirubin blood test market growth during the next few years.

Prominent vendors in bilirubin blood test market

We provide a detailed analysis of around 25 vendors operating in the bilirubin blood test market, including some of the vendors such as Abbott Laboratories, Danaher Corp., Dragerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd., Koninklijke Philips NV, Merck KGaA, Randox Laboratories Ltd., Reichert Inc., Siemens Healthineers AG and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Infants - Market size and forecast 2019-2024
  • Adults - Market size and forecast 2019-2024
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Growing number of strategic alliances
  • Increasing demand for non-invasive procedures
  • Government initiatives and funding for bilirubin testing

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Danaher Corp.
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke Philips NV
  • Merck KGaA
  • Randox Laboratories Ltd.
  • Reichert Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 14: EXPLORE TECHNAVIO

  • Exhibit 01: Global healthcare supplies market
  • Exhibit 02: Segments of global healthcare supplies market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Product overview
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Type - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by type
  • Exhibit 20: Infants - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Infants - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Adults - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Adults - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by type
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Product launch details
  • Exhibit 39: Number of preterm births/LBW infants per 100 live births, 2014
  • Exhibit 40: Product recalls: Overview
  • Exhibit 41: Impact of drivers and challenges
  • Exhibit 42: Business strategies
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Abbott Laboratories - Vendor overview
  • Exhibit 49: Abbott Laboratories - Business segments
  • Exhibit 50: Abbott Laboratories - Organizational developments
  • Exhibit 51: Abbott Laboratories - Geographic focus
  • Exhibit 52: Abbott Laboratories - Segment focus
  • Exhibit 53: Abbott Laboratories - Key offerings
  • Exhibit 54: Abbott Laboratories - Key customers
  • Exhibit 55: Danaher Corp. - Vendor overview
  • Exhibit 56: Danaher Corp. - Business segments
  • Exhibit 57: Danaher Corp. - Organizational developments
  • Exhibit 58: Danaher Corp. - Geographic focus
  • Exhibit 59: Danaher Corp. - Segment focus
  • Exhibit 60: Danaher Corp. - Key offerings
  • Exhibit 61: Danaher Corp. - Key customers
  • Exhibit 62: Dragerwerk AG & Co. KGaA - Vendor overview
  • Exhibit 63: Dragerwerk AG & Co. KGaA - Organizational developments
  • Exhibit 64: Dragerwerk AG & Co. KGaA - Geographic focus
  • Exhibit 65: Dragerwerk AG & Co. KGaA - Key offerings
  • Exhibit 66: Dragerwerk AG & Co. KGaA - Key customers
  • Exhibit 67: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 68: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 69: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 70: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 71: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 72: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 73: F. Hoffmann-La Roche Ltd. - Key customers
  • Exhibit 74: Koninklijke Philips NV - Vendor overview
  • Exhibit 75: Koninklijke Philips NV - Business segments
  • Exhibit 76: Koninklijke Philips NV - Organizational developments
  • Exhibit 77: Koninklijke Philips NV - Geographic focus
  • Exhibit 78: Koninklijke Philips NV - Segment focus
  • Exhibit 79: Koninklijke Philips NV - Key offerings
  • Exhibit 80: Koninklijke Philips NV - Key customers
  • Exhibit 81: Merck KGaA - Vendor overview
  • Exhibit 82: Merck KGaA - Business segments
  • Exhibit 83: Merck KGaA - Organizational developments
  • Exhibit 84: Merck KGaA - Geographic focus
  • Exhibit 85: Merck KGaA - Segment focus
  • Exhibit 86: Merck KGaA - Key offerings
  • Exhibit 87: Merck KGaA - Key customers
  • Exhibit 88: Randox Laboratories Ltd. - Vendor overview
  • Exhibit 89: Randox Laboratories Ltd. - Business segments
  • Exhibit 90: Randox Laboratories Ltd. - Key offerings
  • Exhibit 91: Randox Laboratories Ltd. - Key customers
  • Exhibit 92: Reichert Inc. - Vendor overview
  • Exhibit 93: Reichert Inc. - Business segments
  • Exhibit 94: Reichert Inc. - Key offerings
  • Exhibit 95: Reichert Inc. - Key customers
  • Exhibit 96: Siemens Healthineers AG - Vendor overview
  • Exhibit 97: Siemens Healthineers AG - Business segments
  • Exhibit 98: Siemens Healthineers AG - Organizational developments
  • Exhibit 99: Siemens Healthineers AG - Geographic focus
  • Exhibit 100: Siemens Healthineers AG - Segment focus
  • Exhibit 101: Siemens Healthineers AG - Key offerings
  • Exhibit 102: Siemens Healthineers AG - Key customers
  • Exhibit 103: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 104: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 105: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 106: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 107: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 108: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 109: Thermo Fisher Scientific Inc. - Key customers
  • Exhibit 110: Validation techniques employed for market sizing
  • Exhibit 111: Definition of market positioning of vendors
Back to Top